Healthcare Triangle (NASDAQ:HCTI – Get Free Report) is one of 93 public companies in the “Healthcare Technology” industry, but how does it weigh in compared to its competitors? We will compare Healthcare Triangle to related businesses based on the strength of its earnings, profitability, risk, valuation, institutional ownership, dividends and analyst recommendations.
Earnings & Valuation
This table compares Healthcare Triangle and its competitors revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Healthcare Triangle | $13.89 million | -$9.48 million | -0.01 |
| Healthcare Triangle Competitors | $341.86 million | -$24.15 million | 12.21 |
Healthcare Triangle’s competitors have higher revenue, but lower earnings than Healthcare Triangle. Healthcare Triangle is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Risk & Volatility
Healthcare Triangle has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500. Comparatively, Healthcare Triangle’s competitors have a beta of 1.11, indicating that their average stock price is 11% more volatile than the S&P 500.
Profitability
This table compares Healthcare Triangle and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Healthcare Triangle | -45.37% | -54.80% | -22.80% |
| Healthcare Triangle Competitors | -749.77% | -27.84% | -15.02% |
Insider & Institutional Ownership
0.3% of Healthcare Triangle shares are held by institutional investors. Comparatively, 42.4% of shares of all “Healthcare Technology” companies are held by institutional investors. 0.1% of Healthcare Triangle shares are held by company insiders. Comparatively, 16.2% of shares of all “Healthcare Technology” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Analyst Recommendations
This is a summary of current ratings and price targets for Healthcare Triangle and its competitors, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Healthcare Triangle | 1 | 0 | 0 | 0 | 1.00 |
| Healthcare Triangle Competitors | 456 | 1539 | 2761 | 89 | 2.51 |
As a group, “Healthcare Technology” companies have a potential upside of 48.57%. Given Healthcare Triangle’s competitors stronger consensus rating and higher probable upside, analysts clearly believe Healthcare Triangle has less favorable growth aspects than its competitors.
Summary
Healthcare Triangle competitors beat Healthcare Triangle on 9 of the 12 factors compared.
About Healthcare Triangle
Healthcare Triangle, Inc. provides technology and consulting services to healthcare and life sciences organizations. Its work includes helping clients modernize cloud systems, manage and analyze data, connect disparate health information systems, and address cybersecurity and regulatory-compliance needs. The company offers solutions under the CloudEz, DataEz and InteropX names, covering cloud services, data management and interoperability. It also provides implementation, consulting and ongoing technology support.
Receive News & Ratings for Healthcare Triangle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Triangle and related companies with MarketBeat.com's FREE daily email newsletter.
